CKMH Nephrology
There is no content available at this time. Please check again later.
Relevant Content
Early-Stage CKD Intervention Strategies for Better Outcomes
CKM Care Clinical QuickStart Guide Toolkit
Women's Kidney Health in Focus
Deprescribing in Patients With Cardiovascular Disease Experiencing Polypharmacy
Globally, one in 10 women lives with chronic kidney disease (CKD), which i...
Time of Day as a Biological Variable in Cardiovascular and Kidney Disease Research
Time-of-day is a fundamental biological variable that needs to be consider...
Finerenone Plus Empagliflozin: How Low Can We Go, and How Much Does Blood Pressure Matter?
Hypertension, Volume 83, Issue 9, Page e27364, September 1, 2026.
Letter by Hu et al Regarding Article, “Cell-Specific Inducible Human APOL1 Risk Variant Expression in Mice Causes Hypertension and Renal Damage”
Circulation, Volume 154, Issue 6, Page e235-e236, August 11, 2026.
Response by Poudel and Susztak to Letter Regarding Article, “Cell-Specific Inducible Human APOL1 Risk Variant Expression in Mice Causes Hypertension and Renal Damage”
Circulation, Volume 154, Issue 6, Page e237-e238, August 11, 2026.
Methodologic Standards for Follow-Up Extension in Cardiovascular Trials
Extension follow-up studies address long-term questions beyond the parent...
Comprehensive Clinical Approach to Cardiovascular Kidney Metabolic Syndrome
Polypharmacy is common in cardiovascular (CV) care because guideline-direc...
